Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration
INNOVAPATH · 22.06.2026 · 2 (2) · 5
DOI: 10.63501/azz6za12 ↗Kurz gefasst
Fachartikel in der Zeitschrift INNOVAPATH, online erschienen am 22.06.2026. Verfasst von Rimsha Maqsood und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Microglial activation and sustained neuroinflammation are central features of chronic neurodegenerative diseases. Emerging evidence indicates that microglial function is tightly linked to intracellular metabolic state, with shifts between oxidative phosphorylation (OXPHOS) and glycolysis shaping inflammatory output, phagocytosis, and neurotoxicity.
Objective
To synthesize mechanistic, translational, and disease-specific evidence that positions microglial metabolic reprogramming as a key driver and potential therapeutic target in chronic neurodegeneration.
Methods
Narrative synthesis of preclinical and clinical studies addressing microglial metabolism, mitochondrial dysfunction, inflammasome activation, and immunometabolic interventions.
Findings
Pro-inflammatory stimuli (LPS, amyloid-β, α-synuclein) induce glycolytic reprogramming in microglia, accompanied by mitochondrial dysfunction, ROS generation, and NLRP3 inflammasome activation (3,6,9). Disease-specific evidence links these metabolic shifts to impaired debris clearance and sustained cytokine release in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and ALS (8,10–13). Aging-associated metabolic drift primes microglia toward inflammatory phenotypes (14). Interventions targeting glycolysis, AMPK activation, or NLRP3 show preclinical promise (3,6,16).
Conclusion
Microglial immunometabolism provides a mechanistic bridge between chronic inflammation and neurodegeneration. Precision metabolic modulation of microglia — recalibrating rather than suppressing activity — is a promising translational strategy warranting biomarker-guided clinical evaluation.
Zitieren
APA
Maqsood, R., Mushtaq, A., Nawaz, K., Ikram, E., & Majeed, A. G. (2026). Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration. INNOVAPATH, 2(2), 5. https://doi.org/10.63501/azz6za12
Vancouver
Maqsood R, Mushtaq A, Nawaz K, Ikram E, Majeed AG. Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration. INNOVAPATH. 2026;2(2):5. doi:10.63501/azz6za12
BibTeX
@article{Maqsood2026,
author = {Maqsood, Rimsha and Mushtaq, Areeba and Nawaz, Kainat and Ikram, Ezza and Majeed, Abdul Ghaffar},
title = {Microglial Metabolic Reprogramming: The Missing Link in Chronic Neurodegeneration},
journal = {INNOVAPATH},
year = {2026},
volume = {2},
number = {2},
pages = {5},
doi = {10.63501/azz6za12}
}
EUVIMED